Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04217850 · ClinicalTrials.gov registry record · NA
microRNA Testing for Identification of Personalized Weight Management
A NA study, sponsored by North Dakota State University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04217850: Clinical Trial NA study, sponsored by North Dakota State University.
NCT04217850 is a NA study that was terminated before completion, run by North Dakota State University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04217850, a NA study, was terminated before completion, sponsored by North Dakota State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Certain blood markers are related to one's ability to successfully lose weight by diet and exercise. Currently, the laboratory tests used to measure these blood markers are expensive and time-consuming. Recently, the Electrical and Computer Engineering Department, at NDSU, invented a device that may be able to measure these blood markers much more quickly and affordably. This study is designed participate, to compare our new device to previous methods. If the new sensor is successful, it will be used as diagnostic tool to personalize weight loss strategies.
Primary Outcome
Venous blood concentrations (M) of micro RNA 140 will be measured using our sensor.
Interventions
- OTHER Aerobic Exercise
- OTHER 250 kcal Dietary Energy Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Why NCT04217850 stopped before completion
NCT04217850 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Aerobic Exercise is the first listed.
NCT04217850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04217850 about?
NCT04217850 is a clinical study titled "microRNA Testing for Identification of Personalized Weight Management". Certain blood markers are related to one's ability to successfully lose weight by diet and exercise. Currently, the laboratory tests used to measure these blood markers are expensive and time-consuming. Recently, the Electrical and Computer Engineering Department, at NDSU, invented a device that may...
What is the current status of trial NCT04217850?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2020-01-13. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT04217850?
The interventions under investigation include: Aerobic Exercise (OTHER), 250 kcal Dietary Energy Restriction (OTHER).
Who is sponsoring clinical trial NCT04217850?
This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04217850's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI